Hafnia alvei is the first precision probiotic developed based on a target-based approach and a screening for strains producing ClpB, a protein mimicking alpha-MSH and activating the signals of satiety. Its mechanism of action and demonstration in efficacy in mice and humans make it a uniquely positioned, innovative next-gen probiotic for weight management.